Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Strictly: Drilling II -- Ignore unavailable to you. Want to Upgrade?

To: Louis V. Lambrecht who wrote (19483)	9/24/2002 1:30:07 PM
From: ItsAllCyclical	Read Replies (1) \| Respond to of 36161

Re: CRA. I somewhat agree with your assessment, but I'm looking at two things: 1) CRA has said they are going to start more drug research of their own. Maybe they'll eventually morph into a more traditional bio. 2) My basis is below 7.50. I'm really just looking for $9-10 again and then I'll trim most and hold a small amount LT. Based upon this company's cash/debt levels they have at least 2 years to refocus their business and still have cash levels around $10. Kind of like a LT option at these prices. As far as the "map" being completed I beg to differ. They are finding out that the "map" is far more complex. Not to mention there are other organisms and other ways of leveraging this kind of technology. Didn't mean to make a big deal of it, but someone brought up a a different company trading below cash levels and I thought CRA was interesting here.